Next Article in Journal
Toll-Like Receptor 3 Is Involved in Detection of Enterovirus A71 Infection and Targeted by Viral 2A Protease
Next Article in Special Issue
Seasonality Drives Microbial Community Structure, Shaping both Eukaryotic and Prokaryotic Host–Viral Relationships in an Arctic Marine Ecosystem
Previous Article in Journal
Genetic and Phenotypic Characterization of Cryphonectria hypovirus 1 from Eurasian Georgia
Previous Article in Special Issue
Identification of Dual Receptor Binding Protein Systems in Lactococcal 936 Group Phages

A Wake-Up Call: We Need Phage Therapy Now

by 1,2,*,†, 3,*,† and 4
Institute of Medical Microbiology, University of Zurich, 8006 Zurich, Switzerland
Max Planck Institute for molecular Genetics, 14195 Berlin, Germany
Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
Department Trauma & Orthopedic Surgery, Septic & Reconstructive Surgery, Research and Treatment Center for Complex Combat Injuries, Military Hospital Berlin, 10115 Berlin, Germany
Authors to whom correspondence should be addressed.
These authors contributed equally.
Viruses 2018, 10(12), 688;
Received: 26 October 2018 / Revised: 27 November 2018 / Accepted: 3 December 2018 / Published: 5 December 2018
(This article belongs to the Special Issue Viruses of Microbes V: Biodiversity and Future Applications)
The rise of multidrug-resistant bacteria has resulted in an increased interest in phage therapy, which historically preceded antibiotic treatment against bacterial infections. To date, there have been no reports of serious adverse events caused by phages. They have been successfully used to cure human diseases in Eastern Europe for many decades. More recently, clinical trials and case reports for a variety of indications have shown promising results. However, major hurdles to the introduction of phage therapy in the Western world are the regulatory and legal frameworks. Present regulations may take a decade or longer to be fulfilled. It is of urgent need to speed up the availability of phage therapy. View Full-Text
Keywords: phages; phage therapy; Helsinki declaration; regulation; magistral preparation phages; phage therapy; Helsinki declaration; regulation; magistral preparation
Show Figures

Figure 1

MDPI and ACS Style

Moelling, K.; Broecker, F.; Willy, C. A Wake-Up Call: We Need Phage Therapy Now. Viruses 2018, 10, 688.

AMA Style

Moelling K, Broecker F, Willy C. A Wake-Up Call: We Need Phage Therapy Now. Viruses. 2018; 10(12):688.

Chicago/Turabian Style

Moelling, Karin, Felix Broecker, and Christian Willy. 2018. "A Wake-Up Call: We Need Phage Therapy Now" Viruses 10, no. 12: 688.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop